\n<\/p>\n
Every year, TechCrunch\u2019s Startup Battlefield pitch contest draws thousands of applicants. We whittle those applications down to the top 200 contenders<\/a>, and of them, the top 20 compete on the big stage to become the winner, taking home the Startup Battlefield Cup and a cash prize of $100,000. But the remaining 180 startups all blew us away as well in their respective categories and compete in their own pitch competition.<\/p>\n Here is the full list of the\u00a0biotech and pharma Startup Battlefield 200 selectees, along with a note on why they landed in the competition.\u00a0<\/p>\n What it does:<\/strong> CasNx has invented a new kind of antivirus treatment for organs from organ donors.<\/p>\n Why it\u2019s noteworthy:<\/strong> The startup has invented a gene-editing CRISPR kit that eliminates viruses and installs \u201cuniversal donor\u201d markers while the organ is being preserved outside the body.\u00a0<\/p>\n What it does:<\/strong> Chipiron is building a light and inexpensive, open full-body MRI machine<\/a> intended to make MRI cancer diagnostics more widely available.\u00a0<\/p>\n Why it\u2019s noteworthy: <\/strong>The medical MRI machine is being built using a superconducting quantum interference device (SQUID), a highly sensitive magnetometer that can measure extremely weak magnetic fields, more commonly used in array antennas.\u00a0<\/p>\n What it does<\/strong>: Exactics is building a platform that creates rapid diagnostic tests.\u00a0<\/p>\n Techcrunch event<\/p>\n \n\t\t\t\t\t\t\t\t\tSan Francisco<\/span> Why it\u2019s noteworthy: <\/strong>Exactics is attempting to make consumer diagnostic kits more widely available, beginning with at-home screening of Lyme disease, with kits for other illnesses on the roadmap.\u00a0\u00a0<\/p>\n What it does<\/strong>: Lumos has created a consumer high-frequency electromagnetic device named Avara, targeted at red blood cells.\u00a0<\/p>\n Why it\u2019s noteworthy: <\/strong>Avara has been designed to provide gentle, non-contact \u201cinductive therapy\u201d to improve sleep, relaxation, and exercise recovery.\u00a0<\/p>\n What it does:<\/strong> Miraqules developed a nanotechnology in powder form that mimics blood-clotting proteins<\/a>.\u00a0<\/p>\n Why it\u2019s noteworthy:<\/strong> This technology provides instant blood clotting and is a unique, potentially lifesaving alternative to traditional wound treatments, particularly when treating patients on the scene of the injury.\u00a0<\/p>\n What it does<\/strong>: Nephrogen is creating gene therapy solutions for kidney illnesses.\u00a0<\/p>\n Why it\u2019s noteworthy: <\/strong>Nephrogen is solving the hardest part of the problem when it comes to gene-editing medicines. Its tech uses AI to accurately target gene-editing to the exact cells in the kidney that are causing the illness.\u00a0\u00a0<\/p>\n What it does:<\/strong> PraxisPro is an AI-powered training system for sales and marketing roles in life science industries.\u00a0\u00a0<\/p>\n Why it\u2019s noteworthy:<\/strong> The system provides compliance-approved content, complete with simulations and real-time analytics to ensure those who represent life science companies are properly prepared to do so.\u00a0<\/p>\n What it does:<\/strong> Reme-D is developing reliable and affordable diagnostic tests specifically geared toward underserved communities.\u00a0<\/p>\n Why it\u2019s noteworthy:<\/strong> Reme-D is developing rapid diagnostic tests that are not only particularly affordable but also stable in hot and humid climates.\u00a0<\/p>\n What it does:<\/strong> Surgicure has created a patented solution that more safely and reliably secures endotracheal tubes (ET).\u00a0<\/p>\n Why it\u2019s noteworthy:<\/strong> This device makes ET tubes, the flexible tubes inserted through the mouth or nose during surgeries or other treatments, safer and more comfortable for patients.\u00a0<\/p>\n<\/div>\nCasNx<\/a><\/h5>\n
Chipiron<\/a>\u00a0<\/h5>\n
Exactics?<\/a>\u00a0<\/h5>\n
\n\t\t\t\t\t\t\t\t\t\t\t\t\t|<\/span>
\n\t\t\t\t\t\t\t\t\t\t\t\t\tOctober 13-15, 2026<\/span>\n\t\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\nLumos Strategies O\u00dc?<\/a>\u00a0<\/h5>\n
Miraqules<\/a>\u00a0<\/h5>\n
Nephrogen<\/a>\u00a0<\/h5>\n
PraxisPro<\/a>\u00a0<\/h5>\n
Reme-D<\/a>\u00a0<\/h5>\n
Surgicure Technologies<\/a>\u00a0<\/h5>\n